Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung.
Fangdi SunJames P GrenertLisa TanJessica Van ZiffleNancy M JosephClaire K MulveyEmily K BergslandPublished in: JCO precision oncology (2022)